Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Janssen’s urothelial cancer drug gets breakthrough therapy designation

pharmaceutical-technologyMarch 19, 2018

Tag: Janssen , FDA

PharmaSources Customer Service